Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection.
Level 5 - mechanism / opinion, no new human data
Theoretical hypothesis paper without original empirical data or systematic review methodology.
PubMed 11399122 · doi:10.1054/mehy.2000.1169
What was done
This theoretical hypothesis paper outlines a mechanistic framework connecting male aging, adipose tissue expansion, aromatase activity, testosterone reduction, and cardiometabolic disease. No experimental study, clinical trial, or systematic data synthesis was performed.
What was found
The abstract reports no numerical data or statistical findings. It outlines a conceptual model in which age-associated increases in adipose tissue elevate aromatase activity, accelerating the conversion of testosterone to estradiol. The resulting low testosterone state promotes visceral adiposity, leptin and insulin resistance, dyslipidemia (elevated triglycerides, low HDL), osteopenia, erectile dysfunction, and cardiovascular disease (termed the CHAOS complex).
Why it matters
The paper frames the bidirectional link between low testosterone and visceral adiposity as a self-reinforcing cycle underlying metabolic and cardiovascular decline in aging men.
Limits
The publication is solely a narrative hypothesis without original empirical data, quantitative measurements, control groups, or systematic review methodology.
Cited by
- supports Aromatase enzyme in visceral and abdominal fat converts testosterone into estrogen.